|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-1-4
|
|
pubmed:abstractText |
Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) can both present with an erosive arthritis with the small joints of the hands affected. Therefore a serological marker would be useful to distinguish between these two diseases at onset. In this study anti-RA33 antibodies, which are found in patients with SLE and RA, and anti-citrullinated peptide antibodies (anti-CCP), which have recently been described as highly specific for RA, were assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0003-4967
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-8
|
|
pubmed:dateRevised |
2008-11-20
|
|
pubmed:meshHeading |
pubmed-meshheading:11114286-Antibodies, Antinuclear,
pubmed-meshheading:11114286-Arthritis, Rheumatoid,
pubmed-meshheading:11114286-Autoantibodies,
pubmed-meshheading:11114286-Biological Markers,
pubmed-meshheading:11114286-Citrulline,
pubmed-meshheading:11114286-Diagnosis, Differential,
pubmed-meshheading:11114286-Follow-Up Studies,
pubmed-meshheading:11114286-Humans,
pubmed-meshheading:11114286-Lupus Erythematosus, Systemic,
pubmed-meshheading:11114286-Retrospective Studies,
pubmed-meshheading:11114286-Rheumatoid Factor
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
|
|
pubmed:affiliation |
Centre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
